Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

NCT07554820 is registered in ClinicalTrials.gov with Shaikh Zayed Hospital, Lahore as lead sponsor.

NCT NCT07554820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07554820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL
Lead sponsor
Shaikh Zayed Hospital, Lahore
Phase
Phase 4
Overall status
Recruiting
Start date
December 6, 2025
Completion date
September 30, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major adverse cardiac events, rheumatoid arthritis